Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Debt to Equity (2022 - 2025)

Historic Debt to Equity for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $0.21.

  • PAVmed's Debt to Equity changed N/A to $0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.21, marking a year-over-year change of. This contributed to the annual value of -$4.14 for FY2024, which is 12483.66% down from last year.
  • PAVmed's Debt to Equity amounted to $0.21 in Q3 2025.
  • PAVmed's 5-year Debt to Equity high stood at $3.08 for Q4 2022, and its period low was -$4.14 during Q4 2024.
  • Over the past 4 years, PAVmed's median Debt to Equity value was -$0.45 (recorded in 2025), while the average stood at -$0.59.
  • Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 29147.49% in 2023, then skyrocketed by 10767.66% in 2025.
  • PAVmed's Debt to Equity (Quarter) stood at $3.08 in 2022, then crashed by 159.8% to -$1.84 in 2023, then tumbled by 124.84% to -$4.14 in 2024, then soared by 105.13% to $0.21 in 2025.
  • Its Debt to Equity was $0.21 in Q3 2025, compared to $0.18 in Q2 2025 and $0.15 in Q1 2025.